Patent · US Active

Use of Bifidobacterium longum for the prevention and treatment of inflammation

US8916145B2 · kind B2 · utility

7Cited by

0References

12Claims

0Family size

Assignee

NESTEC S.A. · CH

Inventors

Annick Mercenier · Bussigny, CH
Stephanie Blum-Sperisen · Pully, CH
Florence Rochat · Montreux, CH

Key dates

Filing date	Feb 14, 2007
Grant date	Dec 23, 2014
Priority date	—
Expiry date	Dec 28, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use, in the manufacture of a medicament or a therapeutic nutritional composition for preventing or reducing inflammation in a mammal, of bifidobacterium longum ATCC BAA-999.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.